I've also stayed proactive by reaching out to a Gizmodo Health writer and NPR's Biotech Nation to introduce the technology as an amazed user (which I am)... Moira Gunn replied that one of her producers was already using the Actipatch so I put her in touch with Sree Koneru at BIEL :)
Not sure how many listener/reader leads turn in to content but it doesn't hurt to try...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.